News Quantified

APM – aptorum group limited - class a ordinary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease

Form 6-K Aptorum Group Ltd For: Mar 11

Form 6-K Aptorum Group Ltd For: Mar 06

Form 6-K Aptorum Group Ltd For: Feb 06

Form 6-K Aptorum Group Ltd For: Sep 30

Form S-4/A Aptorum Group Ltd

Top News Gainers

2/10 Aptorum Group Announces Further Positive Data For Its ALS-4 Small Molecule Anti-virulence (Non-bactericidal) Drug Candidate For The Treatment of Infections Caused By Staphylococcus Aureus and On Track Targeted For IND Submission in H2 2020 8.1%

3/30 Aptorum Group Limited to Present at the Solebury Trout Virtual Investor Conference 7.5%

4/29 Aptorum Group Limited to Present at the Infectious Disease Virtual Conference 6.8%

5/15 Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States 6.2%

9/9 Spolecnost Aptorum Group zahájila studie umožnující IND pro kandidáta na prípravek s malou molekulou ALS-4 pro lécbu infekcí zpusobených bakterií Staphylococcus Aureus vcetne MRSA 4.1%

9/30 Form F-1/A Aptorum Group Ltd 3.8%

5/6 Aptorum Group’s Subsidiary - Claves Life Sciences Limited Establishes Novel Therapeutic Platform for Treatment of Various Diseases via Modulation of the Chemical Signaling Relating to Gut Microbiota 3.5%

5/22 Aptorum Group to Be Newly Added to MSCI HK Micro Cap Index 2.8%

2/28 Aptorum Group Announces Closing of $10 Million Registered Direct Offering of Class A Ordinary Shares and Warrants 1.9%

1/13 Form 6-K Aptorum Group Ltd For: Jan 13 1.6%

Top News Decliners

2/26 Aptorum Group Announces Pricing of $10 Million Registered Direct Offering -53.5%

12/31 Aptorum Group Ltd (NASDAQ: APM) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -13.8%

3/10 Form SC 13D/A Aptorum Group Ltd Filed by: HUEN IAN CHUNG YUEN -8.8%

2/26 Aptorum Group Ltd (NASDAQ: APM) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -6.0%

12/18 Form F-3 Aptorum Group Ltd -5.4%

7/2 Form F-1 Aptorum Group Ltd -4.3%

8/16 Form F-1/A Aptorum Group Ltd -3.8%

7/8 Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN -2.9%

2/24 Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong -2.8%

1/16 Form EFFECT Aptorum Group Ltd -2.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day